The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Veterinary Molecular Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
The molecular diagnostic is defined as a technique for used in the laboratory for to identify a disease or its predisposition stage by analyzing the DNA or RNA or other proteins in humans and animals.
The global Veterinary Molecular Diagnostics market size is expected to reach US$ 575.5 million by 2029, growing at a CAGR of 6.6% from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Molecular Diagnostics in various end use industries. The expanding demands from the Veterinary Hospitals, Clinical Laboratories and Research Institutes,, are propelling Veterinary Molecular Diagnostics market. Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reagents segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 119%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Molecular Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Molecular Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Molecular Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Molecular Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Molecular Diagnostics covered in this report include IDEXX Laboratories, VCA, BAXIS, Heska, Zoetis, Neogen, Thermo Fisher Scientific, Virbac and GE Healthcare, etc.
The global Veterinary Molecular Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
IDEXX Laboratories
VCA
BAXIS
Heska
Zoetis
Neogen
Thermo Fisher Scientific
Virbac
GE Healthcare
AGFA Healthcare
Veterinary Molecular Diagnostics
Global Veterinary Molecular Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Molecular Diagnostics market, Segment by Type:
Instruments
Reagents
Services
Software
Global Veterinary Molecular Diagnostics market, by Application
Veterinary Hospitals
Clinical Laboratories
Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Veterinary Molecular Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The molecular diagnostic is defined as a technique for used in the laboratory for to identify a disease or its predisposition stage by analyzing the DNA or RNA or other proteins in humans and animals.
The global Veterinary Molecular Diagnostics market size is expected to reach US$ 575.5 million by 2029, growing at a CAGR of 6.6% from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Molecular Diagnostics in various end use industries. The expanding demands from the Veterinary Hospitals, Clinical Laboratories and Research Institutes,, are propelling Veterinary Molecular Diagnostics market. Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Reagents segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 119%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Molecular Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Molecular Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Molecular Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Molecular Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Molecular Diagnostics covered in this report include IDEXX Laboratories, VCA, BAXIS, Heska, Zoetis, Neogen, Thermo Fisher Scientific, Virbac and GE Healthcare, etc.
The global Veterinary Molecular Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
IDEXX Laboratories
VCA
BAXIS
Heska
Zoetis
Neogen
Thermo Fisher Scientific
Virbac
GE Healthcare
AGFA Healthcare
Veterinary Molecular Diagnostics
Global Veterinary Molecular Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Molecular Diagnostics market, Segment by Type:
Instruments
Reagents
Services
Software
Global Veterinary Molecular Diagnostics market, by Application
Veterinary Hospitals
Clinical Laboratories
Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Veterinary Molecular Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Veterinary Molecular Diagnostics
1.1 Veterinary Molecular Diagnostics Market Overview
1.1.1 Veterinary Molecular Diagnostics Product Scope
1.1.2 Veterinary Molecular Diagnostics Market Status and Outlook
1.2 Global Veterinary Molecular Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Veterinary Molecular Diagnostics Market Size by Region (2018-2029)
1.4 Global Veterinary Molecular Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Veterinary Molecular Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Veterinary Molecular Diagnostics Market Size (2018-2029)
1.6.1 North America Veterinary Molecular Diagnostics Market Size (2018-2029)
1.6.2 Europe Veterinary Molecular Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Veterinary Molecular Diagnostics Market Size (2018-2029)
1.6.4 Latin America Veterinary Molecular Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Veterinary Molecular Diagnostics Market Size (2018-2029)
2 Veterinary Molecular Diagnostics Market by Type
2.1 Introduction
2.1.1 Instruments
2.1.2 Reagents
2.1.3 Services
2.1.4 Software
2.2 Global Veterinary Molecular Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Veterinary Molecular Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Veterinary Molecular Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Veterinary Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Veterinary Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Veterinary Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Veterinary Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Veterinary Molecular Diagnostics Revenue Breakdown by Type (2018-2029)
3 Veterinary Molecular Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Veterinary Hospitals
3.1.2 Clinical Laboratories
3.1.3 Research Institutes
3.2 Global Veterinary Molecular Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Veterinary Molecular Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Veterinary Molecular Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Veterinary Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Veterinary Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Veterinary Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Veterinary Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Veterinary Molecular Diagnostics Revenue Breakdown by Application (2018-2029)
4 Veterinary Molecular Diagnostics Competition Analysis by Players
4.1 Global Veterinary Molecular Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Molecular Diagnostics as of 2022)
4.3 Date of Key Players Enter into Veterinary Molecular Diagnostics Market
4.4 Global Top Players Veterinary Molecular Diagnostics Headquarters and Area Served
4.5 Key Players Veterinary Molecular Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Veterinary Molecular Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 IDEXX Laboratories
5.1.1 IDEXX Laboratories Profile
5.1.2 IDEXX Laboratories Main Business
5.1.3 IDEXX Laboratories Veterinary Molecular Diagnostics Products, Services and Solutions
5.1.4 IDEXX Laboratories Veterinary Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 IDEXX Laboratories Recent Developments
5.2 VCA
5.2.1 VCA Profile
5.2.2 VCA Main Business
5.2.3 VCA Veterinary Molecular Diagnostics Products, Services and Solutions
5.2.4 VCA Veterinary Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 VCA Recent Developments
5.3 BAXIS
5.3.1 BAXIS Profile
5.3.2 BAXIS Main Business
5.3.3 BAXIS Veterinary Molecular Diagnostics Products, Services and Solutions
5.3.4 BAXIS Veterinary Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Heska Recent Developments
5.4 Heska
5.4.1 Heska Profile
5.4.2 Heska Main Business
5.4.3 Heska Veterinary Molecular Diagnostics Products, Services and Solutions
5.4.4 Heska Veterinary Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Heska Recent Developments
5.5 Zoetis
5.5.1 Zoetis Profile
5.5.2 Zoetis Main Business
5.5.3 Zoetis Veterinary Molecular Diagnostics Products, Services and Solutions
5.5.4 Zoetis Veterinary Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Zoetis Recent Developments
5.6 Neogen
5.6.1 Neogen Profile
5.6.2 Neogen Main Business
5.6.3 Neogen Veterinary Molecular Diagnostics Products, Services and Solutions
5.6.4 Neogen Veterinary Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Neogen Recent Developments
5.7 Thermo Fisher Scientific
5.7.1 Thermo Fisher Scientific Profile
5.7.2 Thermo Fisher Scientific Main Business
5.7.3 Thermo Fisher Scientific Veterinary Molecular Diagnostics Products, Services and Solutions
5.7.4 Thermo Fisher Scientific Veterinary Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Thermo Fisher Scientific Recent Developments
5.8 Virbac
5.8.1 Virbac Profile
5.8.2 Virbac Main Business
5.8.3 Virbac Veterinary Molecular Diagnostics Products, Services and Solutions
5.8.4 Virbac Veterinary Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Virbac Recent Developments
5.9 GE Healthcare
5.9.1 GE Healthcare Profile
5.9.2 GE Healthcare Main Business
5.9.3 GE Healthcare Veterinary Molecular Diagnostics Products, Services and Solutions
5.9.4 GE Healthcare Veterinary Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 GE Healthcare Recent Developments
5.10 AGFA Healthcare
5.10.1 AGFA Healthcare Profile
5.10.2 AGFA Healthcare Main Business
5.10.3 AGFA Healthcare Veterinary Molecular Diagnostics Products, Services and Solutions
5.10.4 AGFA Healthcare Veterinary Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 AGFA Healthcare Recent Developments
5.11 Veterinary Molecular Diagnostics
5.11.1 Veterinary Molecular Diagnostics Profile
5.11.2 Veterinary Molecular Diagnostics Main Business
5.11.3 Veterinary Molecular Diagnostics Veterinary Molecular Diagnostics Products, Services and Solutions
5.11.4 Veterinary Molecular Diagnostics Veterinary Molecular Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 Veterinary Molecular Diagnostics Recent Developments
6 North America
6.1 North America Veterinary Molecular Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Veterinary Molecular Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Molecular Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Veterinary Molecular Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Molecular Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Veterinary Molecular Diagnostics Market Dynamics
11.1 Veterinary Molecular Diagnostics Industry Trends
11.2 Veterinary Molecular Diagnostics Market Drivers
11.3 Veterinary Molecular Diagnostics Market Challenges
11.4 Veterinary Molecular Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
